• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

ZCL278

CAS No. 587841-73-4

ZCL278 ( ZCL 278 | ZCL-278 )

产品货号. M15167 CAS No. 587841-73-4

一种有效的细胞渗透性 Cdc42 特异性小分子抑制剂 (Kd=6.4 uM)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥567 有现货
10MG ¥911 有现货
25MG ¥1609 有现货
50MG ¥2678 有现货
100MG ¥3852 有现货
200MG ¥5373 有现货
500MG ¥8019 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥822 有现货

生物学信息

  • 产品名称
    ZCL278
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种有效的细胞渗透性 Cdc42 特异性小分子抑制剂 (Kd=6.4 uM)。
  • 产品描述
    A potent, cell-permeable Cdc42-specific small-molecule inhibitor (Kd=6.4 uM); specifically targets Cdc42–intersectin interaction and inhibits Cdc42-mediated cellular processes, including Golgi organization and cell motility.
  • 体外实验
    ZCL278 as a potent, cell-permeable Cdc42-specific inhibitor that suppresses actin-based cellular functions, including Golgi organization and cell motility.In Swiss 3T3 fibroblast cultures, ZCL278 abolishes microspike formation and disrupted GM130-docked Golgi structures, two of the most prominent Cdc42-mediated subcellular events. ZCL278 reduces the perinuclear accumulation of active Cdc42 in contrast to NSC23766, a selective Rac inhibitor. ZCL278 suppresses Cdc42-mediated neuronal branching and growth cone dynamics as well as actin-based motility and migration in a metastatic prostate cancer cell line (i.e., PC-3) without disrupting cell viability. ZCL278 inhibits Cdc42 function as an entry inhibitor for Junin virus (JUNV) and for vesicular stomatitis virus, lymphocytic choriomeningitis virus, and dengue virus but not for the nonenveloped poliovirus. In cells, ZCL278 is shown to efficiently inhibit chemically induced filopodium formation, a process dependent on Cdc42 activity. Dose-response experiments are first carried out in Vero cells, and while ZCL278 is not toxic at concentrations up to 200 μM, ZCL278 inhibits JUNV with IC50 of ~14 μM, as measured by flow cytometry.
  • 体内实验
    ZCL278 reduces the JUNV RNA load in the spleen more than 33-fold, with JUNV RNA being undetectable in 5 out of 8 mice. These results are similar to those seen in Gabapentin-treated mice, demonstrating that ZCL278 can abrogate JUNV replication.
  • 同义词
    ZCL 278 | ZCL-278
  • 通路
    MAPK/ERK Signaling
  • 靶点
    Ras
  • 受体
    Cdc42GTPase
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    587841-73-4
  • 分子量
    584.8937
  • 分子式
    C21H19BrClN5O4S2
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C(NC(NC1=CC=C(S(=O)(NC2=NC(C)=CC(C)=N2)=O)C=C1)=S)COC3=CC=C(Br)C=C3Cl
  • 化学全称
    Acetamide, 2-(4-bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Friesland A, et al. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1261-6. 2. Liu X, et al. Cell Physiol Biochem. 2015;36(4):1613-27.
产品手册
关联产品
  • KRAS G12C inhibitor ...

    一种有效、选择性、共价 KRAS G12C 抑制剂,可在亚微摩尔浓度下选择性抑制 KRAS G12C 依赖性信号传导和癌细胞生长。

  • (R)-BI-2852

    (R)-BI-2852 是 BI-2852 (HY-126247) 的非活性异构体,可作为实验中的对照化合物。BI-2852 是基于活性分子结构设计的 switch SI/II 口袋的 KRAS 抑制剂,其通过基于结构的活性分子设计具有纳摩尔亲和力。BI-2852 在机理上不同于共价 KRASG12C 抑制剂 (结合 switch II),与活性 KRASG12D 结合强度是与 KRAS wt 的 10 倍 (740 nM vs 7.5 μM)。BI-2852 阻断 GEF,GAP 和效应子与 KRAS 的相互作用,导致下游信号传导的抑制和 KRAS 突变细胞中的抗增殖作用。

  • K-Ras G12C-IN-12

    致癌 K-Ras(G12C) 的变构抑制剂,在 H1792 细胞中 EC50 为 0.32 uM。